首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events
【24h】

Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events

机译:GlycA和其他炎症生物标志物对总死亡,心血管事件,非心血管和非癌性炎症相关事件以及癌症总事件的预测价值的比较

获取原文
           

摘要

BACKGROUND: GlycA is a biomarker that reflects integrated concentrations and glycosylation states of several acute-phase proteins. We studied the association of GlycA and inflammatory biomarkers with future death and disease.METHODS: A total of 6523 men and women in the Multi-Ethnic Study of Atherosclerosis who were free of overt cardiovascular disease (CVD) and in generally good health had a baseline blood sample taken. We assayed high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and d-dimer. A spectral deconvolution algorithm was used to quantify GlycA signal amplitudes from automated nuclear magnetic resonance (NMR) LipoProfile? test spectra. Median follow-up was 12.1 years. Among 4 primary outcomes, CVD events were adjudicated, death was by death certificate, and chronic inflammatory-related severe hospitalization and death (ChrIRD) and total cancer were classified using International Classification of Diseases (ICD) codes. We used Poisson regression to study baseline GlycA, hsCRP, IL-6, and d-dimer in relation to total death, CVD, ChrIRD, and total cancer.RESULTS: Relative risk per SD of GlycA, IL-6, and d-dimer for total death (n = 915); for total CVD (n = 922); and for ChrIRD (n = 1324) ranged from 1.05 to 1.20, independently of covariates. In contrast, prediction from hsCRP was statistically explained by adjustment for other inflammatory variables. Only GlycA was predictive for total cancer (n = 663). Women had 7% higher values of all inflammatory biomarkers than men and had a significantly lower GlycA prediction coefficient than men in predicting total cancer.CONCLUSIONS: The composite biomarker GlycA derived from NMR is associated with risk for total death, CVD, ChrIRD, and total cancer after adjustment for hsCRP, IL-6, and d-dimer. IL-6 and d-dimer contribute information independently of GlycA.
机译:背景:GlycA是一种生物标记,可反映几种急性期蛋白的整合浓度和糖基化状态。我们研究了GlycA和炎性生物标志物与未来死亡和疾病的关系。方法:动脉粥样硬化多民族研究中共有6523名男性和女性没有基线心血管疾病(CVD),总体上健康状况良好采血样。我们测定了高敏C反应蛋白(hsCRP),白介素6(IL-6)和d-二聚体。频谱去卷积算法用于从自动核磁共振(NMR)LipoProfile?中量化GlycA信号幅度。测试光谱。中位随访时间为12。1年。在4个主要结局中,对CVD事件进行裁决,通过死亡证明书确定死亡,并使用国际疾病分类(ICD)代码对慢性炎症相关的严重住院和死亡(ChrIRD)和总癌症进行分类。我们使用Poisson回归研究基线GlycA,hsCRP,IL-6和d-二聚体与总死亡,CVD,ChrIRD和总癌症的相关性。结果:GlycA,IL-6和d-二聚体的每SD相对风险总死亡人数(n = 915);对于总CVD(n = 922);对于ChrIRD(n = 1324),范围从1.05至1.20,与协变量无关。相反,通过调整其他炎症变量可以从统计学上解释hsCRP的预测。只有GlycA可以预测总癌症(n = 663)。在预测总癌症中,女性的所有炎症性生物标志物值均比男性高7%,而GlycA的预测系数则明显低于男性。调整hsCRP,IL-6和d-二聚体后的癌症。 IL-6和d-二聚体独立于GlycA贡献信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号